Zheng, XiaoyingGuo, WeiZeng, LinZheng, DanniYang, ShuoWang, LinaWang, RuiMol, Ben W.Li, RongQiao, Jie2020-06-182020-06-182020-04Zheng, X, Guo, W, Zeng, L, Zheng, D, Yang, S, Wang, L, Wang, R, Mol, B W, Li, R & Qiao, J 2020, 'Live birth after in vitro maturation versus standard in vitro fertilisation for women with polycystic ovary syndrome : protocol for a non-inferiority randomised clinical trial', BMJ Open, vol. 10, no. 4, 035334. https://doi.org/10.1136/bmjopen-2019-0353342044-6055https://hdl.handle.net/2164/14533Funding This study was supported by the National Key Research and Development Program of China (2016YFC1000201; 2018YFC1002104) and the National Science Foundation of China (81730038). The study funders had no rule in the study design, implementation, analysis, manuscript, preparation, or decision to submit this article for publication.8528821engSDG 3 - Good Health and Well-beinggynaecologyreproductive medicineGNRH ANTAGONISTIVMINFERTILITYOOCYTESFROZENFRESHR MedicineGeneral MedicineRLive birth after in vitro maturation versus standard in vitro fertilisation for women with polycystic ovary syndrome : protocol for a non-inferiority randomised clinical trialJournal article10.1136/bmjopen-2019-035334http://www.scopus.com/inward/record.url?scp=85083436442&partnerID=8YFLogxK104